Publication | Closed Access

ICAM-3 endows anticancer drug resistance against microtubule-damaging agents via activation of the ICAM-3-AKT/ERK-CREB-2 pathway and blockage of apoptosis

Icam-3-akt/erk-creb-2 PathwayMedicineApoptosisAutophagyCell DeathImmune Checkpoint InhibitorIcam-3 EndowsAnti-cancer AgentPharmacologyCell BiologyCell SignalingCancer ResearchDrug Resistance